anti-MESO CAR-T cells

BIOLOGICAL2 trials

Sponsors

Zhejiang University, Second Affiliated Hospital, School of Medicine, Zhejiang University

Conditions

Ovarian Cancer

Early Phase 1

MESO-CAR T Cells Therapy for Relapsed and Refractory Ovarian Cancer

Zhejiang UniversityOvarian Cancer

Start: 2019-04-10End: 2022-04-30Target: 20Updated: 2019-04-10

Phase 1

MESO-CAR T Cells Therapy for Relapsed and Refractory Epithelial Ovarian Cancer

Second Affiliated Hospital, School of Medicine, Zhejiang UniversityOvarian Cancer

Start: 2019-04-20End: 2023-04-20Target: 20Updated: 2019-04-16